Lobe Sciences Ltd. (LOBEF)
OTCMKTS · Delayed Price · Currency is USD
0.0326
-0.0049 (-13.07%)
Sep 8, 2025, 3:10 PM EDT
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of $7.25 million as of September 8, 2025. Its market cap has increased by 521.33% in one year.
Market Cap
7.25M
Enterprise Value
9.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has decreased from 13.11M to 7.25M, a decrease of -44.68%. That is a compound annual growth rate of -9.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 7.25M | 127.73% |
| Dec 31, 2024 | 3.18M | 112.53% |
| Dec 29, 2023 | 1.50M | -33.91% |
| Dec 30, 2022 | 2.27M | -57.44% |
| Dec 31, 2021 | 5.33M | -73.34% |
| Dec 31, 2020 | 19.98M | 339.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |